Literature DB >> 7377864

NK and K cell activity of human blood: differences according to sex, age, and disease.

J Penschow, I R Mackay.   

Abstract

We report a study on the activity of NK cells ('natural' killer cells) and K cells (antibody-dependent killer cells) in human peripheral blood in health and disease. The 'targets' used were cells of the Chang cell-line, sensitised with rabbit anti-Chang cell antibody for K cell activity, and killing was assessed by release of radiochromium at effector: target ratios of 50:1 and 100:1. The positive findings were that NK cell activity, but not K cell activity, was greater in males and in youth, that NK cell activity was reduced in systemic lupus erythematosus, that neither NK nor K cell activity was altered in rheumatoid arthritis, and that K cell activity was reduced in chronic active hepatitis.

Entities:  

Mesh:

Year:  1980        PMID: 7377864      PMCID: PMC1000475          DOI: 10.1136/ard.39.1.82

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  Antibody dependent cytolytic effector lymphocytes (K cells) in human blood.

Authors:  P Perlmann; H Perlmann; A Larsson; B Wåhlin
Journal:  J Reticuloendothel Soc       Date:  1975-04

2.  Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis.

Authors:  B H Toh; I C Roberts-Thomson; J D Mathews; S Whittingham; I R Mackay
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

Review 3.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays.

Authors:  E B Rosenberg; J L McCoy; S S Green; F C Donnelly; D F Siwarski; P H Levine; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

5.  Letter: HL-A 3,7 and lymphocyte cytotoxic activity.

Authors:  G G Petrányi; M Benczur; C E Onody; S R Hollán
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes.

Authors:  I C MacLennan; G Loewi; A Howard
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

8.  Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  E Diaz-Jouanen; A D Bankhurst; R C Williams
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

9.  Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus.

Authors:  J Schneider; W Chin; G J Friou; S M Cooper; B Harding; R L Hill; F P Quismorio
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

10.  Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations.

Authors:  M Jondal; H Pross
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

View more
  12 in total

1.  Age-dependent altered proportions in subpopulations of tonsillar lymphocytes.

Authors:  W Bergler; S Adam; H J Gross; K Hörmann; R Schwartz-Albiez
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Activated, cytotoxic lymphocytes in systemic vasculitis.

Authors:  A D Blann; D G Scott
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  The relationship between the frequency of the common cold and the activities of natural killer cells.

Authors:  M Xu; T Muto; T Yabe; F Nagao; Y Fukuwatart; K Okumura
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

4.  In vitro zinc correction of natural killer (NK) activity in the elderly.

Authors:  M T Ventura; R Crollo; E Lasaracina
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 5.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

6.  Natural killer cell activity in untreated systemic lupus erythematosus.

Authors:  K Oshimi; M Sumiya; N Gonda; S Kano; F Takaku
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.

Authors:  I R Mackay; M D Goodyear; C Riglar; J Penschow
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

9.  Serology, clinical manifestations and treatment of brucellosis in different age groups.

Authors:  J D Colmenero; J M Reguera; F P Cabrera; J M Cisneros; D L Orjuela; J Fernández-Crehuet
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

10.  Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG.

Authors:  R Mandeville; F M Sombo; N Rocheleau
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.